Personalized medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most promising tools.

Memorial Sloan Kettering Cancer Center investigators report that T cell interferon-γ (IFNγ) orchestrates a ...

Cancer patients living in southern Utah and nearby states now have a facility offering a highly specialized treatment much ...

During a live event, Nathan M. Denlinger, DO, MS, discussed the PILOT and ALYCANTE trials of CAR T-cell therapy in transplant-ineligible B-cell lymphoma.

As people age, their immune systems become less efficient, posing a challenge for cancer therapies that rely on harnessing immune cells.